The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Highlights
The global Drug Eluting Coronary Stent market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Drug Eluting Coronary Stent is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Drug Eluting Coronary Stent is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Drug Eluting Coronary Stent include Boston Scientific, Medtronic, Abbott, Sahajanand Laser Technology Limited (SLTL Group), Meril Life Sciences, Concept Medical, BIOTRONIK, Relisys and Lepu Medical Technology(Beijing), etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Drug Eluting Coronary Stent in Angina Pectoris is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Sirolimus, which accounted for % of the global market of Drug Eluting Coronary Stent in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Drug Eluting Coronary Stent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Eluting Coronary Stent.
The Drug Eluting Coronary Stent market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drug Eluting Coronary Stent market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Eluting Coronary Stent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Some of the prominent players reviewed in the research report include:
- Boston Scientific
- Medtronic
- Abbott
- Sahajanand Laser Technology Limited (SLTL Group)
- Meril Life Sciences
- Concept Medical
- BIOTRONIK
- Relisys
- Lepu Medical Technology(Beijing)
- Micell Technologies
- Terumo Corporation
- Biosensors International
Product Type Insights
Global markets are presented by Drug Eluting Coronary Stent type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Drug Eluting Coronary Stent are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Drug Eluting Coronary Stent segment by Type
- Sirolimus
- Everolimus
- Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Drug Eluting Coronary Stent market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug Eluting Coronary Stent market.
Drug Eluting Coronary Stent segment by Application
- Angina Pectoris
- Myocardial Infarction
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Drug Eluting Coronary Stent market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Eluting Coronary Stent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Drug Eluting Coronary Stent and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Eluting Coronary Stent industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Eluting Coronary Stent.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Drug Eluting Coronary Stent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Drug Eluting Coronary Stent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index
1 Drug Eluting Coronary Stent Market Overview
1.1 Product Overview and Scope of Drug Eluting Coronary Stent
1.2 Drug Eluting Coronary Stent Segment by Type
1.2.1 Global Drug Eluting Coronary Stent Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Sirolimus
1.2.3 Everolimus
1.2.4 Others
1.3 Drug Eluting Coronary Stent Segment by Application
1.3.1 Global Drug Eluting Coronary Stent Sales Comparison by Application: (2022-2028)
1.3.2 Angina Pectoris
1.3.3 Myocardial Infarction
1.4 Global Drug Eluting Coronary Stent Market Size Estimates and Forecasts
1.4.1 Global Drug Eluting Coronary Stent Revenue 2017-2028
1.4.2 Global Drug Eluting Coronary Stent Sales 2017-2028
1.4.3 Drug Eluting Coronary Stent Market Size by Region: 2017 Versus 2021 Versus 2028
2 Drug Eluting Coronary Stent Market Competition by Manufacturers
2.1 Global Drug Eluting Coronary Stent Sales Market Share by Manufacturers (2017-2022)
2.2 Global Drug Eluting Coronary Stent Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Drug Eluting Coronary Stent Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Drug Eluting Coronary Stent Manufacturing Sites, Area Served, Product Type
2.5 Drug Eluting Coronary Stent Market Competitive Situation and Trends
2.5.1 Drug Eluting Coronary Stent Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Drug Eluting Coronary Stent Players Market Share by Revenue
2.5.3 Global Drug Eluting Coronary Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Drug Eluting Coronary Stent Retrospective Market Scenario by Region
3.1 Global Drug Eluting Coronary Stent Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Drug Eluting Coronary Stent Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Drug Eluting Coronary Stent Market Facts & Figures by Country
3.3.1 North America Drug Eluting Coronary Stent Sales by Country
3.3.2 North America Drug Eluting Coronary Stent Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Drug Eluting Coronary Stent Market Facts & Figures by Country
3.4.1 Europe Drug Eluting Coronary Stent Sales by Country
3.4.2 Europe Drug Eluting Coronary Stent Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Drug Eluting Coronary Stent Market Facts & Figures by Region
3.5.1 Asia Pacific Drug Eluting Coronary Stent Sales by Region
3.5.2 Asia Pacific Drug Eluting Coronary Stent Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Drug Eluting Coronary Stent Market Facts & Figures by Country
3.6.1 Latin America Drug Eluting Coronary Stent Sales by Country
3.6.2 Latin America Drug Eluting Coronary Stent Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Drug Eluting Coronary Stent Market Facts & Figures by Country
3.7.1 Middle East and Africa Drug Eluting Coronary Stent Sales by Country
3.7.2 Middle East and Africa Drug Eluting Coronary Stent Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Drug Eluting Coronary Stent Historic Market Analysis by Type
4.1 Global Drug Eluting Coronary Stent Sales Market Share by Type (2017-2022)
4.2 Global Drug Eluting Coronary Stent Revenue Market Share by Type (2017-2022)
4.3 Global Drug Eluting Coronary Stent Price by Type (2017-2022)
5 Global Drug Eluting Coronary Stent Historic Market Analysis by Application
5.1 Global Drug Eluting Coronary Stent Sales Market Share by Application (2017-2022)
5.2 Global Drug Eluting Coronary Stent Revenue Market Share by Application (2017-2022)
5.3 Global Drug Eluting Coronary Stent Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Boston Scientific
6.1.1 Boston Scientific Corporation Information
6.1.2 Boston Scientific Description and Business Overview
6.1.3 Boston Scientific Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Boston Scientific Drug Eluting Coronary Stent Product Portfolio
6.1.5 Boston Scientific Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Corporation Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Medtronic Drug Eluting Coronary Stent Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Abbott Drug Eluting Coronary Stent Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Sahajanand Laser Technology Limited (SLTL Group)
6.4.1 Sahajanand Laser Technology Limited (SLTL Group) Corporation Information
6.4.2 Sahajanand Laser Technology Limited (SLTL Group) Description and Business Overview
6.4.3 Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Product Portfolio
6.4.5 Sahajanand Laser Technology Limited (SLTL Group) Recent Developments/Updates
6.5 Meril Life Sciences
6.5.1 Meril Life Sciences Corporation Information
6.5.2 Meril Life Sciences Description and Business Overview
6.5.3 Meril Life Sciences Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Meril Life Sciences Drug Eluting Coronary Stent Product Portfolio
6.5.5 Meril Life Sciences Recent Developments/Updates
6.6 Concept Medical
6.6.1 Concept Medical Corporation Information
6.6.2 Concept Medical Description and Business Overview
6.6.3 Concept Medical Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Concept Medical Drug Eluting Coronary Stent Product Portfolio
6.6.5 Concept Medical Recent Developments/Updates
6.7 BIOTRONIK
6.6.1 BIOTRONIK Corporation Information
6.6.2 BIOTRONIK Description and Business Overview
6.6.3 BIOTRONIK Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.4.4 BIOTRONIK Drug Eluting Coronary Stent Product Portfolio
6.7.5 BIOTRONIK Recent Developments/Updates
6.8 Relisys
6.8.1 Relisys Corporation Information
6.8.2 Relisys Description and Business Overview
6.8.3 Relisys Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Relisys Drug Eluting Coronary Stent Product Portfolio
6.8.5 Relisys Recent Developments/Updates
6.9 Lepu Medical Technology(Beijing)
6.9.1 Lepu Medical Technology(Beijing) Corporation Information
6.9.2 Lepu Medical Technology(Beijing) Description and Business Overview
6.9.3 Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Product Portfolio
6.9.5 Lepu Medical Technology(Beijing) Recent Developments/Updates
6.10 Micell Technologies
6.10.1 Micell Technologies Corporation Information
6.10.2 Micell Technologies Description and Business Overview
6.10.3 Micell Technologies Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Micell Technologies Drug Eluting Coronary Stent Product Portfolio
6.10.5 Micell Technologies Recent Developments/Updates
6.11 Terumo Corporation
6.11.1 Terumo Corporation Corporation Information
6.11.2 Terumo Corporation Drug Eluting Coronary Stent Description and Business Overview
6.11.3 Terumo Corporation Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Terumo Corporation Drug Eluting Coronary Stent Product Portfolio
6.11.5 Terumo Corporation Recent Developments/Updates
6.12 Biosensors International
6.12.1 Biosensors International Corporation Information
6.12.2 Biosensors International Drug Eluting Coronary Stent Description and Business Overview
6.12.3 Biosensors International Drug Eluting Coronary Stent Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Biosensors International Drug Eluting Coronary Stent Product Portfolio
6.12.5 Biosensors International Recent Developments/Updates
7 Drug Eluting Coronary Stent Manufacturing Cost Analysis
7.1 Drug Eluting Coronary Stent Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Drug Eluting Coronary Stent
7.4 Drug Eluting Coronary Stent Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Drug Eluting Coronary Stent Distributors List
8.3 Drug Eluting Coronary Stent Customers
9 Drug Eluting Coronary Stent Market Dynamics
9.1 Drug Eluting Coronary Stent Industry Trends
9.2 Drug Eluting Coronary Stent Market Drivers
9.3 Drug Eluting Coronary Stent Market Challenges
9.4 Drug Eluting Coronary Stent Market Restraints
10 Global Market Forecast
10.1 Drug Eluting Coronary Stent Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Drug Eluting Coronary Stent by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Drug Eluting Coronary Stent by Type (2023-2028)
10.2 Drug Eluting Coronary Stent Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Drug Eluting Coronary Stent by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Drug Eluting Coronary Stent by Application (2023-2028)
10.3 Drug Eluting Coronary Stent Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Drug Eluting Coronary Stent by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Drug Eluting Coronary Stent by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Drug Eluting Coronary Stent Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Drug Eluting Coronary Stent Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Drug Eluting Coronary Stent Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Drug Eluting Coronary Stent Market Competitive Situation by Manufacturers in 2021
Table 5. Global Drug Eluting Coronary Stent Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Drug Eluting Coronary Stent Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Drug Eluting Coronary Stent Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Drug Eluting Coronary Stent Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Drug Eluting Coronary Stent Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Drug Eluting Coronary Stent Manufacturing Sites and Area Served
Table 11. Manufacturers Drug Eluting Coronary Stent Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Drug Eluting Coronary Stent by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Eluting Coronary Stent as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Drug Eluting Coronary Stent Sales by Region (2017-2022) & (K Units)
Table 16. Global Drug Eluting Coronary Stent Sales Market Share by Region (2017-2022)
Table 17. Global Drug Eluting Coronary Stent Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Drug Eluting Coronary Stent Revenue Market Share by Region (2017-2022)
Table 19. North America Drug Eluting Coronary Stent Sales by Country (2017-2022) & (K Units)
Table 20. North America Drug Eluting Coronary Stent Sales Market Share by Country (2017-2022)
Table 21. North America Drug Eluting Coronary Stent Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Drug Eluting Coronary Stent Revenue Market Share by Country (2017-2022)
Table 23. Europe Drug Eluting Coronary Stent Sales by Country (2017-2022) & (K Units)
Table 24. Europe Drug Eluting Coronary Stent Sales Market Share by Country (2017-2022)
Table 25. Europe Drug Eluting Coronary Stent Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Drug Eluting Coronary Stent Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Drug Eluting Coronary Stent Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Drug Eluting Coronary Stent Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Drug Eluting Coronary Stent Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Drug Eluting Coronary Stent Revenue Market Share by Region (2017-2022)
Table 31. Latin America Drug Eluting Coronary Stent Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Drug Eluting Coronary Stent Sales Market Share by Country (2017-2022)
Table 33. Latin America Drug Eluting Coronary Stent Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Drug Eluting Coronary Stent Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Drug Eluting Coronary Stent Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Drug Eluting Coronary Stent Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Drug Eluting Coronary Stent Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Drug Eluting Coronary Stent Revenue Market Share by Country (2017-2022)
Table 39. Global Drug Eluting Coronary Stent Sales by Type (2017-2022) & (K Units)
Table 40. Global Drug Eluting Coronary Stent Sales Market Share by Type (2017-2022)
Table 41. Global Drug Eluting Coronary Stent Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Drug Eluting Coronary Stent Revenue Share by Type (2017-2022)
Table 43. Global Drug Eluting Coronary Stent Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Drug Eluting Coronary Stent Sales (K Units) by Application (2017-2022)
Table 45. Global Drug Eluting Coronary Stent Sales Market Share by Application (2017-2022)
Table 46. Global Drug Eluting Coronary Stent Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Drug Eluting Coronary Stent Revenue Share by Application (2017-2022)
Table 48. Global Drug Eluting Coronary Stent Price by Application (2017-2022) & (US$/Unit)
Table 49. Boston Scientific Corporation Information
Table 50. Boston Scientific Description and Business Overview
Table 51. Boston Scientific Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Boston Scientific Drug Eluting Coronary Stent Product
Table 53. Boston Scientific Recent Developments/Updates
Table 54. Medtronic Corporation Information
Table 55. Medtronic Description and Business Overview
Table 56. Medtronic Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Medtronic Drug Eluting Coronary Stent Product
Table 58. Medtronic Recent Developments/Updates
Table 59. Abbott Corporation Information
Table 60. Abbott Description and Business Overview
Table 61. Abbott Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Abbott Drug Eluting Coronary Stent Product
Table 63. Abbott Recent Developments/Updates
Table 64. Sahajanand Laser Technology Limited (SLTL Group) Corporation Information
Table 65. Sahajanand Laser Technology Limited (SLTL Group) Description and Business Overview
Table 66. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Sahajanand Laser Technology Limited (SLTL Group) Drug Eluting Coronary Stent Product
Table 68. Sahajanand Laser Technology Limited (SLTL Group) Recent Developments/Updates
Table 69. Meril Life Sciences Corporation Information
Table 70. Meril Life Sciences Description and Business Overview
Table 71. Meril Life Sciences Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. Meril Life Sciences Drug Eluting Coronary Stent Product
Table 73. Meril Life Sciences Recent Developments/Updates
Table 74. Concept Medical Corporation Information
Table 75. Concept Medical Description and Business Overview
Table 76. Concept Medical Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Concept Medical Drug Eluting Coronary Stent Product
Table 78. Concept Medical Recent Developments/Updates
Table 79. BIOTRONIK Corporation Information
Table 80. BIOTRONIK Description and Business Overview
Table 81. BIOTRONIK Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. BIOTRONIK Drug Eluting Coronary Stent Product
Table 83. BIOTRONIK Recent Developments/Updates
Table 84. Relisys Corporation Information
Table 85. Relisys Description and Business Overview
Table 86. Relisys Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Relisys Drug Eluting Coronary Stent Product
Table 88. Relisys Recent Developments/Updates
Table 89. Lepu Medical Technology(Beijing) Corporation Information
Table 90. Lepu Medical Technology(Beijing) Description and Business Overview
Table 91. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Lepu Medical Technology(Beijing) Drug Eluting Coronary Stent Product
Table 93. Lepu Medical Technology(Beijing) Recent Developments/Updates
Table 94. Micell Technologies Corporation Information
Table 95. Micell Technologies Description and Business Overview
Table 96. Micell Technologies Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Micell Technologies Drug Eluting Coronary Stent Product
Table 98. Micell Technologies Recent Developments/Updates
Table 99. Terumo Corporation Corporation Information
Table 100. Terumo Corporation Description and Business Overview
Table 101. Terumo Corporation Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 102. Terumo Corporation Drug Eluting Coronary Stent Product
Table 103. Terumo Corporation Recent Developments/Updates
Table 104. Biosensors International Corporation Information
Table 105. Biosensors International Description and Business Overview
Table 106. Biosensors International Drug Eluting Coronary Stent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 107. Biosensors International Drug Eluting Coronary Stent Product
Table 108. Biosensors International Recent Developments/Updates
Table 109. Production Base and Market Concentration Rate of Raw Material
Table 110. Key Suppliers of Raw Materials
Table 111. Drug Eluting Coronary Stent Distributors List
Table 112. Drug Eluting Coronary Stent Customers List
Table 113. Drug Eluting Coronary Stent Market Trends
Table 114. Drug Eluting Coronary Stent Market Drivers
Table 115. Drug Eluting Coronary Stent Market Challenges
Table 116. Drug Eluting Coronary Stent Market Restraints
Table 117. Global Drug Eluting Coronary Stent Sales Forecast by Type (2023-2028) & (K Units)
Table 118. Global Drug Eluting Coronary Stent Sales Market Share Forecast by Type (2023-2028)
Table 119. Global Drug Eluting Coronary Stent Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 120. Global Drug Eluting Coronary Stent Revenue Market Share Forecast by Type (2023-2028)
Table 121. Global Drug Eluting Coronary Stent Sales Forecast by Application (2023-2028) & (K Units)
Table 122. Global Drug Eluting Coronary Stent Sales Market Share Forecast by Application (2023-2028)
Table 123. Global Drug Eluting Coronary Stent Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 124. Global Drug Eluting Coronary Stent Revenue Market Share Forecast by Application (2023-2028)
Table 125. Global Drug Eluting Coronary Stent Sales Forecast by Region (2023-2028) & (K Units)
Table 126. Global Drug Eluting Coronary Stent Sales Market Share Forecast by Region (2023-2028)
Table 127. Global Drug Eluting Coronary Stent Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 128. Global Drug Eluting Coronary Stent Revenue Market Share Forecast by Region (2023-2028)
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Drug Eluting Coronary Stent
Figure 2. Global Drug Eluting Coronary Stent Market Share by Type in 2021 & 2028
Figure 3. Sirolimus Product Picture
Figure 4. Everolimus Product Picture
Figure 5. Others Product Picture
Figure 6. Global Drug Eluting Coronary Stent Market Share by Application in 2021 & 2028
Figure 7. Angina Pectoris
Figure 8. Myocardial Infarction
Figure 9. Global Drug Eluting Coronary Stent Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Drug Eluting Coronary Stent Market Size (2017-2028) & (US$ Million)
Figure 11. Global Drug Eluting Coronary Stent Sales (2017-2028) & (K Units)
Figure 12. Drug Eluting Coronary Stent Sales Share by Manufacturers in 2021
Figure 13. Global Drug Eluting Coronary Stent Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Drug Eluting Coronary Stent Players: Market Share by Revenue in 2021
Figure 15. Drug Eluting Coronary Stent Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Drug Eluting Coronary Stent Sales Market Share by Region (2017-2022)
Figure 17. Global Drug Eluting Coronary Stent Sales Market Share by Region in 2021
Figure 18. Global Drug Eluting Coronary Stent Revenue Market Share by Region (2017-2022)
Figure 19. Global Drug Eluting Coronary Stent Revenue Market Share by Region in 2021
Figure 20. United States Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Drug Eluting Coronary Stent Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Drug Eluting Coronary Stent by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Drug Eluting Coronary Stent
Figure 44. Manufacturing Process Analysis of Drug Eluting Coronary Stent
Figure 45. Drug Eluting Coronary Stent Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
